Face masks for the prevention of COVID-19 - Rationale and design of the randomised controlled trial DANMASK-19.
Identifieur interne : 000568 ( Main/Exploration ); précédent : 000567; suivant : 000569Face masks for the prevention of COVID-19 - Rationale and design of the randomised controlled trial DANMASK-19.
Auteurs : Henning Bundgaard [Danemark] ; Johan Skov Bundgaard ; Daniel Emil Tadeusz Raaschou-Pedersen ; Anton Friis Mariager ; Natasja Schytte ; Christian Von Buchwald ; Tobias Todsen ; Kerstin Skovgaard ; Romona Trebbien ; Mikkel Porsborg Andersen ; Thomas Benfield ; Henrik Ullum ; Christian Torp-Pedersen ; Kasper IversenSource :
- Danish medical journal [ 2245-1919 ] ; 2020.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Appréciation des risques (MeSH), Contrôle des maladies transmissibles (méthodes), Danemark (MeSH), Femelle (MeSH), Humains (MeSH), Incidence (MeSH), Infections à coronavirus (prévention et contrôle), Masques (statistiques et données numériques), Mâle (MeSH), Organisation mondiale de la santé (MeSH), Pandémies (prévention et contrôle), Pneumopathie virale (prévention et contrôle), Prévention primaire (instrumentation), Prévention primaire (méthodes), Santé publique (MeSH), Sujet âgé (MeSH), Transmission verticale de maladie infectieuse (prévention et contrôle).
- MESH :
- méthodes : Contrôle des maladies transmissibles, Prévention primaire.
- prévention et contrôle : Infections à coronavirus, Pandémies, Pneumopathie virale, Transmission verticale de maladie infectieuse.
- statistiques et données numériques : Masques.
- Adulte, Adulte d'âge moyen, Appréciation des risques, Danemark, Femelle, Humains, Incidence, Mâle, Organisation mondiale de la santé, Prévention primaire, Santé publique, Sujet âgé.
- Wicri :
- geographic : Danemark.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Communicable Disease Control (methods), Coronavirus Infections (prevention & control), Denmark (MeSH), Female (MeSH), Humans (MeSH), Incidence (MeSH), Infectious Disease Transmission, Vertical (prevention & control), Male (MeSH), Masks (statistics & numerical data), Middle Aged (MeSH), Pandemics (prevention & control), Pneumonia, Viral (prevention & control), Primary Prevention (instrumentation), Primary Prevention (methods), Public Health (MeSH), Risk Assessment (MeSH), World Health Organization (MeSH).
- MESH :
- geographic : Denmark.
- instrumentation : Primary Prevention.
- methods : Communicable Disease Control, Primary Prevention.
- prevention & control : Coronavirus Infections, Infectious Disease Transmission, Vertical, Pandemics, Pneumonia, Viral.
- statistics & numerical data : Masks.
- Adult, Aged, Female, Humans, Incidence, Male, Middle Aged, Public Health, Risk Assessment, World Health Organization.
Abstract
INTRODUCTION
The coronavirus disease 19 (COVID-19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), progresses globally, and means to reduce the transmission are needed. In the community, the use of face masks is increasing world-wide, but documentation for the efficacy of this remedy is lacking. This trial investigates whether the use of face masks in the community will reduce wearers' risk of SARS-CoV-2 infection.
METHODS
This study will be a two-arm, unblinded, randomised controlled trial. We will include adults (>18 years of age) without prior confirmed COVID-19 or symptoms suggestive of COVID-19, who spend more than three hours per day outside the home with exposure to other people. A total of 6,000 participants are randomly assigned 1:1 to use face masks or not for a 30-day period during the pandemic. Participants will perform self-testing; quick test for SARS-CoV-2 antibodies (immunoglobulin M (IgM) and immunoglobulin G (IgG)) (the Livzon lateral flow test) and oropharyngeal/nasal swabs for viral detection using polymerase chain reaction (PCR). The primary endpoint following the 30-day study period is the difference in the number of SARS-CoV-2-infected individuals between the two study groups as assessed by a positive nasopharyngeal swap, a positive antibody test or a hospital-based diagnosis of SARS-CoV-2 infection.
CONCLUSIONS
We will study whether a face mask protects the wearer of the mask against SARS-CoV-2 infection. The findings are expected to apply to the present pandemic and to future viral outbreaks and to provide evidence for authority recommendations across the world.
FUNDING
This study was funded by Salling Fondene.
TRIAL REGISTRATION
ClinicalTrials.gov Identifier: NCT04337541.
PubMed: 32829745
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Face masks for the prevention of COVID-19 - Rationale and design of the randomised controlled trial DANMASK-19.</title><author><name sortKey="Bundgaard, Henning" sort="Bundgaard, Henning" uniqKey="Bundgaard H" first="Henning" last="Bundgaard">Henning Bundgaard</name><affiliation wicri:level="1"><nlm:affiliation>henning.bundgaard@regionh.dk.</nlm:affiliation><country wicri:rule="url">Danemark</country></affiliation></author><author><name sortKey="Bundgaard, Johan Skov" sort="Bundgaard, Johan Skov" uniqKey="Bundgaard J" first="Johan Skov" last="Bundgaard">Johan Skov Bundgaard</name></author><author><name sortKey="Raaschou Pedersen, Daniel Emil Tadeusz" sort="Raaschou Pedersen, Daniel Emil Tadeusz" uniqKey="Raaschou Pedersen D" first="Daniel Emil Tadeusz" last="Raaschou-Pedersen">Daniel Emil Tadeusz Raaschou-Pedersen</name></author><author><name sortKey="Mariager, Anton Friis" sort="Mariager, Anton Friis" uniqKey="Mariager A" first="Anton Friis" last="Mariager">Anton Friis Mariager</name></author><author><name sortKey="Schytte, Natasja" sort="Schytte, Natasja" uniqKey="Schytte N" first="Natasja" last="Schytte">Natasja Schytte</name></author><author><name sortKey="Von Buchwald, Christian" sort="Von Buchwald, Christian" uniqKey="Von Buchwald C" first="Christian" last="Von Buchwald">Christian Von Buchwald</name></author><author><name sortKey="Todsen, Tobias" sort="Todsen, Tobias" uniqKey="Todsen T" first="Tobias" last="Todsen">Tobias Todsen</name></author><author><name sortKey="Skovgaard, Kerstin" sort="Skovgaard, Kerstin" uniqKey="Skovgaard K" first="Kerstin" last="Skovgaard">Kerstin Skovgaard</name></author><author><name sortKey="Trebbien, Romona" sort="Trebbien, Romona" uniqKey="Trebbien R" first="Romona" last="Trebbien">Romona Trebbien</name></author><author><name sortKey="Andersen, Mikkel Porsborg" sort="Andersen, Mikkel Porsborg" uniqKey="Andersen M" first="Mikkel Porsborg" last="Andersen">Mikkel Porsborg Andersen</name></author><author><name sortKey="Benfield, Thomas" sort="Benfield, Thomas" uniqKey="Benfield T" first="Thomas" last="Benfield">Thomas Benfield</name></author><author><name sortKey="Ullum, Henrik" sort="Ullum, Henrik" uniqKey="Ullum H" first="Henrik" last="Ullum">Henrik Ullum</name></author><author><name sortKey="Torp Pedersen, Christian" sort="Torp Pedersen, Christian" uniqKey="Torp Pedersen C" first="Christian" last="Torp-Pedersen">Christian Torp-Pedersen</name></author><author><name sortKey="Iversen, Kasper" sort="Iversen, Kasper" uniqKey="Iversen K" first="Kasper" last="Iversen">Kasper Iversen</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32829745</idno><idno type="pmid">32829745</idno><idno type="wicri:Area/Main/Corpus">000518</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000518</idno><idno type="wicri:Area/Main/Curation">000518</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000518</idno><idno type="wicri:Area/Main/Exploration">000518</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Face masks for the prevention of COVID-19 - Rationale and design of the randomised controlled trial DANMASK-19.</title><author><name sortKey="Bundgaard, Henning" sort="Bundgaard, Henning" uniqKey="Bundgaard H" first="Henning" last="Bundgaard">Henning Bundgaard</name><affiliation wicri:level="1"><nlm:affiliation>henning.bundgaard@regionh.dk.</nlm:affiliation><country wicri:rule="url">Danemark</country></affiliation></author><author><name sortKey="Bundgaard, Johan Skov" sort="Bundgaard, Johan Skov" uniqKey="Bundgaard J" first="Johan Skov" last="Bundgaard">Johan Skov Bundgaard</name></author><author><name sortKey="Raaschou Pedersen, Daniel Emil Tadeusz" sort="Raaschou Pedersen, Daniel Emil Tadeusz" uniqKey="Raaschou Pedersen D" first="Daniel Emil Tadeusz" last="Raaschou-Pedersen">Daniel Emil Tadeusz Raaschou-Pedersen</name></author><author><name sortKey="Mariager, Anton Friis" sort="Mariager, Anton Friis" uniqKey="Mariager A" first="Anton Friis" last="Mariager">Anton Friis Mariager</name></author><author><name sortKey="Schytte, Natasja" sort="Schytte, Natasja" uniqKey="Schytte N" first="Natasja" last="Schytte">Natasja Schytte</name></author><author><name sortKey="Von Buchwald, Christian" sort="Von Buchwald, Christian" uniqKey="Von Buchwald C" first="Christian" last="Von Buchwald">Christian Von Buchwald</name></author><author><name sortKey="Todsen, Tobias" sort="Todsen, Tobias" uniqKey="Todsen T" first="Tobias" last="Todsen">Tobias Todsen</name></author><author><name sortKey="Skovgaard, Kerstin" sort="Skovgaard, Kerstin" uniqKey="Skovgaard K" first="Kerstin" last="Skovgaard">Kerstin Skovgaard</name></author><author><name sortKey="Trebbien, Romona" sort="Trebbien, Romona" uniqKey="Trebbien R" first="Romona" last="Trebbien">Romona Trebbien</name></author><author><name sortKey="Andersen, Mikkel Porsborg" sort="Andersen, Mikkel Porsborg" uniqKey="Andersen M" first="Mikkel Porsborg" last="Andersen">Mikkel Porsborg Andersen</name></author><author><name sortKey="Benfield, Thomas" sort="Benfield, Thomas" uniqKey="Benfield T" first="Thomas" last="Benfield">Thomas Benfield</name></author><author><name sortKey="Ullum, Henrik" sort="Ullum, Henrik" uniqKey="Ullum H" first="Henrik" last="Ullum">Henrik Ullum</name></author><author><name sortKey="Torp Pedersen, Christian" sort="Torp Pedersen, Christian" uniqKey="Torp Pedersen C" first="Christian" last="Torp-Pedersen">Christian Torp-Pedersen</name></author><author><name sortKey="Iversen, Kasper" sort="Iversen, Kasper" uniqKey="Iversen K" first="Kasper" last="Iversen">Kasper Iversen</name></author></analytic><series><title level="j">Danish medical journal</title><idno type="eISSN">2245-1919</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Communicable Disease Control (methods)</term><term>Coronavirus Infections (prevention & control)</term><term>Denmark (MeSH)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Incidence (MeSH)</term><term>Infectious Disease Transmission, Vertical (prevention & control)</term><term>Male (MeSH)</term><term>Masks (statistics & numerical data)</term><term>Middle Aged (MeSH)</term><term>Pandemics (prevention & control)</term><term>Pneumonia, Viral (prevention & control)</term><term>Primary Prevention (instrumentation)</term><term>Primary Prevention (methods)</term><term>Public Health (MeSH)</term><term>Risk Assessment (MeSH)</term><term>World Health Organization (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Appréciation des risques (MeSH)</term><term>Contrôle des maladies transmissibles (méthodes)</term><term>Danemark (MeSH)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Incidence (MeSH)</term><term>Infections à coronavirus (prévention et contrôle)</term><term>Masques (statistiques et données numériques)</term><term>Mâle (MeSH)</term><term>Organisation mondiale de la santé (MeSH)</term><term>Pandémies (prévention et contrôle)</term><term>Pneumopathie virale (prévention et contrôle)</term><term>Prévention primaire (instrumentation)</term><term>Prévention primaire (méthodes)</term><term>Santé publique (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Transmission verticale de maladie infectieuse (prévention et contrôle)</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Denmark</term></keywords><keywords scheme="MESH" qualifier="instrumentation" xml:lang="en"><term>Primary Prevention</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Communicable Disease Control</term><term>Primary Prevention</term></keywords><keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Contrôle des maladies transmissibles</term><term>Prévention primaire</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term><term>Infectious Disease Transmission, Vertical</term><term>Pandemics</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Infections à coronavirus</term><term>Pandémies</term><term>Pneumopathie virale</term><term>Transmission verticale de maladie infectieuse</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Masks</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Masques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Middle Aged</term><term>Public Health</term><term>Risk Assessment</term><term>World Health Organization</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Appréciation des risques</term><term>Danemark</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Mâle</term><term>Organisation mondiale de la santé</term><term>Prévention primaire</term><term>Santé publique</term><term>Sujet âgé</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Danemark</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>INTRODUCTION</b></p><p>The coronavirus disease 19 (COVID-19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), progresses globally, and means to reduce the transmission are needed. In the community, the use of face masks is increasing world-wide, but documentation for the efficacy of this remedy is lacking. This trial investigates whether the use of face masks in the community will reduce wearers' risk of SARS-CoV-2 infection.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>This study will be a two-arm, unblinded, randomised controlled trial. We will include adults (>18 years of age) without prior confirmed COVID-19 or symptoms suggestive of COVID-19, who spend more than three hours per day outside the home with exposure to other people. A total of 6,000 participants are randomly assigned 1:1 to use face masks or not for a 30-day period during the pandemic. Participants will perform self-testing; quick test for SARS-CoV-2 antibodies (immunoglobulin M (IgM) and immunoglobulin G (IgG)) (the Livzon lateral flow test) and oropharyngeal/nasal swabs for viral detection using polymerase chain reaction (PCR). The primary endpoint following the 30-day study period is the difference in the number of SARS-CoV-2-infected individuals between the two study groups as assessed by a positive nasopharyngeal swap, a positive antibody test or a hospital-based diagnosis of SARS-CoV-2 infection.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>We will study whether a face mask protects the wearer of the mask against SARS-CoV-2 infection. The findings are expected to apply to the present pandemic and to future viral outbreaks and to provide evidence for authority recommendations across the world.</p></div><div type="abstract" xml:lang="en"><p><b>FUNDING</b></p><p>This study was funded by Salling Fondene.</p></div><div type="abstract" xml:lang="en"><p><b>TRIAL REGISTRATION</b></p><p>ClinicalTrials.gov Identifier: NCT04337541.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32829745</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2245-1919</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>18</Day></PubDate></JournalIssue><Title>Danish medical journal</Title><ISOAbbreviation>Dan Med J</ISOAbbreviation></Journal><ArticleTitle>Face masks for the prevention of COVID-19 - Rationale and design of the randomised controlled trial DANMASK-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">A05200363</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The coronavirus disease 19 (COVID-19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), progresses globally, and means to reduce the transmission are needed. In the community, the use of face masks is increasing world-wide, but documentation for the efficacy of this remedy is lacking. This trial investigates whether the use of face masks in the community will reduce wearers' risk of SARS-CoV-2 infection.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study will be a two-arm, unblinded, randomised controlled trial. We will include adults (>18 years of age) without prior confirmed COVID-19 or symptoms suggestive of COVID-19, who spend more than three hours per day outside the home with exposure to other people. A total of 6,000 participants are randomly assigned 1:1 to use face masks or not for a 30-day period during the pandemic. Participants will perform self-testing; quick test for SARS-CoV-2 antibodies (immunoglobulin M (IgM) and immunoglobulin G (IgG)) (the Livzon lateral flow test) and oropharyngeal/nasal swabs for viral detection using polymerase chain reaction (PCR). The primary endpoint following the 30-day study period is the difference in the number of SARS-CoV-2-infected individuals between the two study groups as assessed by a positive nasopharyngeal swap, a positive antibody test or a hospital-based diagnosis of SARS-CoV-2 infection.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We will study whether a face mask protects the wearer of the mask against SARS-CoV-2 infection. The findings are expected to apply to the present pandemic and to future viral outbreaks and to provide evidence for authority recommendations across the world.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">This study was funded by Salling Fondene.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov Identifier: NCT04337541.</AbstractText><CopyrightInformation>Articles published in the DMJ are “open access”. This means that the articles are distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bundgaard</LastName><ForeName>Henning</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>henning.bundgaard@regionh.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bundgaard</LastName><ForeName>Johan Skov</ForeName><Initials>JS</Initials></Author><Author ValidYN="Y"><LastName>Raaschou-Pedersen</LastName><ForeName>Daniel Emil Tadeusz</ForeName><Initials>DET</Initials></Author><Author ValidYN="Y"><LastName>Mariager</LastName><ForeName>Anton Friis</ForeName><Initials>AF</Initials></Author><Author ValidYN="Y"><LastName>Schytte</LastName><ForeName>Natasja</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>von Buchwald</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Todsen</LastName><ForeName>Tobias</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Skovgaard</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Trebbien</LastName><ForeName>Romona</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Mikkel Porsborg</ForeName><Initials>MP</Initials></Author><Author ValidYN="Y"><LastName>Benfield</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Ullum</LastName><ForeName>Henrik</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Torp-Pedersen</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Iversen</LastName><ForeName>Kasper</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04337541</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Dan Med J</MedlineTA><NlmUniqueID>101576205</NlmUniqueID><ISSNLinking>2245-1919</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003718" MajorTopicYN="N" Type="Geographic">Denmark</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018445" MajorTopicYN="N">Infectious Disease Transmission, Vertical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008397" MajorTopicYN="N">Masks</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011322" MajorTopicYN="N">Primary Prevention</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="Y">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014944" MajorTopicYN="N">World Health Organization</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32829745</ArticleId><ArticleId IdType="pii">A05200363</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Danemark</li></country></list><tree><noCountry><name sortKey="Andersen, Mikkel Porsborg" sort="Andersen, Mikkel Porsborg" uniqKey="Andersen M" first="Mikkel Porsborg" last="Andersen">Mikkel Porsborg Andersen</name><name sortKey="Benfield, Thomas" sort="Benfield, Thomas" uniqKey="Benfield T" first="Thomas" last="Benfield">Thomas Benfield</name><name sortKey="Bundgaard, Johan Skov" sort="Bundgaard, Johan Skov" uniqKey="Bundgaard J" first="Johan Skov" last="Bundgaard">Johan Skov Bundgaard</name><name sortKey="Iversen, Kasper" sort="Iversen, Kasper" uniqKey="Iversen K" first="Kasper" last="Iversen">Kasper Iversen</name><name sortKey="Mariager, Anton Friis" sort="Mariager, Anton Friis" uniqKey="Mariager A" first="Anton Friis" last="Mariager">Anton Friis Mariager</name><name sortKey="Raaschou Pedersen, Daniel Emil Tadeusz" sort="Raaschou Pedersen, Daniel Emil Tadeusz" uniqKey="Raaschou Pedersen D" first="Daniel Emil Tadeusz" last="Raaschou-Pedersen">Daniel Emil Tadeusz Raaschou-Pedersen</name><name sortKey="Schytte, Natasja" sort="Schytte, Natasja" uniqKey="Schytte N" first="Natasja" last="Schytte">Natasja Schytte</name><name sortKey="Skovgaard, Kerstin" sort="Skovgaard, Kerstin" uniqKey="Skovgaard K" first="Kerstin" last="Skovgaard">Kerstin Skovgaard</name><name sortKey="Todsen, Tobias" sort="Todsen, Tobias" uniqKey="Todsen T" first="Tobias" last="Todsen">Tobias Todsen</name><name sortKey="Torp Pedersen, Christian" sort="Torp Pedersen, Christian" uniqKey="Torp Pedersen C" first="Christian" last="Torp-Pedersen">Christian Torp-Pedersen</name><name sortKey="Trebbien, Romona" sort="Trebbien, Romona" uniqKey="Trebbien R" first="Romona" last="Trebbien">Romona Trebbien</name><name sortKey="Ullum, Henrik" sort="Ullum, Henrik" uniqKey="Ullum H" first="Henrik" last="Ullum">Henrik Ullum</name><name sortKey="Von Buchwald, Christian" sort="Von Buchwald, Christian" uniqKey="Von Buchwald C" first="Christian" last="Von Buchwald">Christian Von Buchwald</name></noCountry><country name="Danemark"><noRegion><name sortKey="Bundgaard, Henning" sort="Bundgaard, Henning" uniqKey="Bundgaard H" first="Henning" last="Bundgaard">Henning Bundgaard</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000568 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000568 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidSeniorV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32829745
|texte= Face masks for the prevention of COVID-19 - Rationale and design of the randomised controlled trial DANMASK-19.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32829745" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidSeniorV1
| This area was generated with Dilib version V0.6.37. |  |